Inspired by patients. Driven by science.
UCB – Inspired by patients. Driven by science. At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We look to transform patients’ lives by pushing the boundaries of what is possible. With us, our talents makes the most of who they are, unlocking innovation and setting new standards for patients.
Everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?”
And to find the answers, we connect globally with patients and their families living with the physical and social burdens of severe disease. These connections give us new perspectives, drive our innovation, and offer a hope for a new generation of therapies that will help to transform lives.
UCB – The Facts
With approximately 9000 employees in around 40 countries, we are a global biopharmaceutical company headquartered in Brussels, Belgium which invests more than 25% of revenue in cutting-edge scientific research to meet unmet patient needs.
A few other reasons that make UCB an amazing place to work:
- Promising pipeline that includes several novel molecules;
- 2023 Key Financials: € 5.3 billion global revenue
Specialties: Neurology, Immunology
Neurology, Immunology, and Healthcare Innovation Beyond Medicine
Home | UCB
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
Women Deliver healthtech, Civic and Social Organizations | Other 3 Jun 2019 | | ||
Boston Children's Hospital Hospitals and Health Care | Other 12 Nov 2018 | | ||
Biden Foundation edtech, Government Administration | Other 6 Sep 2018 | | ||
The Carter Center healthtech, Non-profit Organizations | Other 13 Apr 2022 | | ||
Cleveland Clinic Hospitals and Health Care | Other 23 Oct 2018 | | ||
Columbia University Irving Medical Center healthtech, Hospitals and Health Care | Other 25 Sep 2018 | | ||
PharmaVoice Pharmaceutical Manufacturing | Other 8 Jun 2020 | | ||
France Assos Santé healthtech, Government Administration | Other 15 Apr 2021 | | ||
Eli Lilly and Company Pharmaceutical Manufacturing | Other 8 Nov 2019 | | ||
Le Monde Newspaper Publishing | Other 13 Dec 2020 | |